CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011-2018.
Emily E RicottaD Rebecca PrevotsKenneth N OlivierPublished in: ERJ open research (2022)
CFTR modulator therapy is associated with a decreased risk of NTM positivity in individuals with cystic fibrosis.